New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 180, Issue 6, Pages 808-820
Publisher
Wiley
Online
2018-02-22
DOI
10.1111/bjh.15132
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-time Characterization of Antibody Binding to Receptors on Living Immune Cells
- (2017) Sina Bondza et al. Frontiers in Immunology
- A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface
- (2016) Rob N. de Jong et al. PLOS BIOLOGY
- Ofatumumab and its role as immunotherapy in chronic lymphocytic leukemia
- (2015) S. Sandhu et al. HAEMATOLOGICA
- Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting
- (2015) Saskia Meyer et al. mAbs
- Ofatumumab and its role as immunotherapy in chronic lymphocytic leukemia
- (2015) S. Sandhu et al. HAEMATOLOGICA
- Reformatting Rituximab into Human IgG2 and IgG4 Isotypes Dramatically Improves Apoptosis Induction In Vitro
- (2015) Jennifer D. Könitzer et al. PLoS One
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
- (2014) C. A. Diebolder et al. SCIENCE
- Response to: Monoclonal antibodies targeting CD20
- (2013) Christian Klein et al. mAbs
- Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
- (2013) Christian Klein et al. mAbs
- A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: Proof of principle with rituximab and ofatumumab
- (2012) Patrick J. Engelberts et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Anti-CD20 Antibody Therapy for B-Cell Lymphomas
- (2012) David G. Maloney NEW ENGLAND JOURNAL OF MEDICINE
- Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies
- (2011) G. Niederfellner et al. BLOOD
- The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden
- (2011) P. Boross et al. HAEMATOLOGICA
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
- (2010) E. Mossner et al. BLOOD
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
- (2010) B. Coiffier et al. BLOOD
- Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection
- (2010) S. A. Beers et al. BLOOD
- Rituximab
- (2010) Gillian M. Keating DRUGS
- BM-ca is a newly defined type I/II anti-CD20 monoclonal antibody with unique biological properties
- (2010) Nishida INTERNATIONAL JOURNAL OF ONCOLOGY
- Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects
- (2010) David M. Goldenberg et al. LEUKEMIA & LYMPHOMA
- CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies
- (2010) Stephen A. Beers et al. SEMINARS IN HEMATOLOGY
- Jalview Version 2--a multiple sequence alignment editor and analysis workbench
- (2009) A. M. Waterhouse et al. BIOINFORMATICS
- Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma
- (2009) B. Li et al. BLOOD
- Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope
- (2009) Susumu Uchiyama et al. CANCER SCIENCE
- Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies
- (2009) Gadi Gazit Bornstein et al. INVESTIGATIONAL NEW DRUGS
- Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody
- (2008) D. M. Goldenberg et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started